par Berghmans, Thierry
;Lafitte, Jean-Jacques;Scherpereel, Arnaud;Paesmans, Marianne
;Lecomte, Jacques;Marco, Vicente Giner;Meert, Anne-Pascale
;Leclercq, Nathalie
;Sculier, Jean-Paul
;European Lung Cancer Working Party,
Référence Anticancer research, 33, 12, page (5477-5482)
Publication Publié, 2013-12





Référence Anticancer research, 33, 12, page (5477-5482)
Publication Publié, 2013-12
Article révisé par les pairs
Résumé : | Aim: While meta-analyses and clinical trials show improved survival in advanced NSCLC treated with platinum-containing chemotherapy, there are few data concerning front-line platinum-free ifosfamide-based regimens. We aimed to compare cisplatin-based chemotherapy to ifosfamide-gemcitabine (IG) with pre-defined second-line docetaxel. |